tm logo
IAMBIC THERAPEUTICS
Live/Pending
PUBLISHED FOR OPPOSITION

on 05 Nov 2024

Last Applicant/ Owned by

4470 W SUNSET BLVD, SUITE 107 PMB 94758

LOS ANGELES

CA

90027

Serial Number

97905484 filed on 25th Apr 2023

Registration Number

N/A

Correspondent Address

Alyssa M. Worsham

Alyssa M. Worsham WILSON SONSINI GOODRICH & ROSATI

PALO ALTO, CA 94304

United States

Filing Basis

1. intent to use

2. intent to use current

Disclaimer

NO DATA

IAMBIC THERAPEUTICS

research and development in the field of computational biology, bioinformatics, and genomics; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; pharmaceutical, medical, scientific, biotechnology, and biopharmaceutical research and development; technical scientific consultation and product development for others in the field of biotechnology Read More

Classification Information


Class [042]
Computer & Software Services & Scientific Services


research and development in the field of computational biology, bioinformatics, and genomics; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; pharmaceutical, medical, scientific, biotechnology, and biopharmaceutical research and development; technical scientific consultation and product development for others in the field of biotechnology and immunology; development of pharmaceuticals; research and development of pharmaceutical preparations and substances for use in clinical trials; scientific and technological services, namely, research and design in the field of computational chemistry, machine learning and artificial intelligence for use in chemistry, biology, physics, biochemistry, chemical engineering, and computer science, and design and optimization of molecules, materials, and drugs; chemistry services, namely, laboratory research in the fields of chemistry and design of new chemistry; chemistry services in the nature of drug, and molecular discovery services, and product development services; chemical research and chemistry consultation in the field of drug and molecular development; industrial analysis and research services being scientific research in the field of drug, materials, and molecular development; technical data analysis services being technology advisory services relating to computer programs for use in chemistry, biology, physics, biochemistry, chemical engineering, computer science, and the discovery of new molecules, materials, drugs, and machine learning techniques; computer programming in the fields of molecular, materials, and drug development; computer consultancy services being computer software consultation in the field of drug, materials, and molecular development; computer software consultation services, namely, assistance and consulting in connection with the development of computer applications, databases and systems for use in the field of drug, materials, and molecular development; consulting services in the design and implementation of computer-based information systems for business, namely, provision of online information relating to computer hardware and software design in the field of drug, materials, and molecular development; creation, maintenance, hosting, and design of websites in the field of drug, materials, and molecular development; provision of online non-downloadable software for simulations for drug, materials, and molecular discovery; software as a service (SAAS) services featuring computer software platforms for use in optimizing drug, materials, and molecular discovery; platform as a service (PAAS) featuring computer software platforms for use in optimizing drug, materials, and molecular discovery; creating website based indexes of information for others using information technology for use in the field of drug, materials, and molecular development; computer graphics design services, namely, realization of computer graphics and digital imaging for use in the field of drug, materials, and molecular development; scientific research in connection with computerized automation of technical processes for use in the field of drug, materials, and molecular development; software as a services (SAAS) services in the nature of hosting cloud-based computing featuring software for optimizing the development of new molecules and designing and discovering molecules, drugs, battery materials, and other molecular products


First Use Date in General

N/A

First Use Date in Commerce

N/A

Mark Details


Serial Number

No 97905484

Mark Type

No Service Mark

Attorney Docket Number

No 59215-TM1004

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History


Show more

Status DateAction Taken
05th Nov 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
05th Nov 2024PUBLISHED FOR OPPOSITION
16th Oct 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
25th Sep 2024APPROVED FOR PUB - PRINCIPAL REGISTER
13th Sep 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
13th Sep 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
13th Sep 2024TEAS/EMAIL CORRESPONDENCE ENTERED
16th Jul 2024APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
16th Jul 2024APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
17th Apr 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED